Given the altered DNA methylation patterns and DNMT expression in UL, demethylation of human uterine leiomyoma cells by this DNMT inhibitor could reduce leiomyoma size, offering a new therapeutic option. The gene discussed is DNMT1; the disease is Uterine leiomyoma.